Genesco, Inc. (GCO) Posts Strong Q4 Results, Comps Up 12%; Guides FY13 Above the Street
Tweet
Share
E-mailGet Alerts GCO Hot Sheet
Price: $35.07 +2.69%
EPS Growth %: -20.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
BTTX, VAXX, ELYS, More
EPS Growth %: -20.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Genesco, Inc. (NYSE: GCO) reported Q4 EPS of $1.97, vs. the analyst estimate of $1.67. Revenue for the quarter came in at $723 million versus the consensus estimate of $722.4 million.
Same-store sales were up 12 percent.
Genesco, Inc. sees FY2013 EPS of $4.58-$4.70, versus the consensus of $4.42.
For earnings history and earnings-related data on Genesco, Inc. (GCO) click here.
Same-store sales were up 12 percent.
Genesco, Inc. sees FY2013 EPS of $4.58-$4.70, versus the consensus of $4.42.
For earnings history and earnings-related data on Genesco, Inc. (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
